Metabolite: HMDB0015532 (Zinc)
Term: Cilostazol Action Pathway
Definition: cilostazol and several of its metabolites are cyclic amp (camp) phosphodiesterase iii inhibitors (pde iii inhibitors), inhibiting phosphodiesterase activity and suppressing camp degradation with a resultant increase in camp in platelets and blood vessels, leading to inhibition of platelet aggregation and vasodilation.
Parent Term: Biochemical pathway
Parent Definition: A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.
Other Metabolites Mapped to 'Cilostazol Action Pathway'